Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 epitope–specific CD4 + memory T cell responses across COVID-19 disease severity and antibody durability
Ryan Nelson, Yuezhou Chen, Olivia Venezia, et al.
Science Immunology (2022) Vol. 7, Iss. 73
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

T Cell Responses to SARS-CoV-2
Alessandro Sette, John Sidney, Shane Crotty
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 343-373
Closed Access | Times Cited: 114
Modeling and analyzing single-cell multimodal data with deep parametric inference
Huan Hu, Zhen Feng, Hai Lin, et al.
Briefings in Bioinformatics (2023) Vol. 24, Iss. 1
Closed Access | Times Cited: 53
Immune recall improves antibody durability and breadth to SARS-CoV-2 variants
Yuezhou Chen, Pei Tong, Noah B. Whiteman, et al.
Science Immunology (2022) Vol. 7, Iss. 78
Open Access | Times Cited: 63
Defending against SARS-CoV-2: The T cell perspective
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, Estela Paz‐Artal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36
Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19
Meng Yu, Afandi Charles, Alberto Cagigi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines
Raju Sunagar, Amit Kumar Singh, Sudeep Kumar
Vaccines (2023) Vol. 11, Iss. 4, pp. 849-849
Open Access | Times Cited: 23
SARS-CoV-2—The Role of Natural Immunity: A Narrative Review
Sara Diani, Erika Leonardi, Attilio Cavezzi, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6272-6272
Open Access | Times Cited: 33
The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development
Haiyun Yu, Fei Guan, Heather Miller, et al.
Emerging Microbes & Infections (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 29
The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein
Noe Juvenal Mendoza-Ramírez, Julio García‐Cordero, Gaurav Shrivastava, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-18
Open Access | Times Cited: 5
SARS-CoV-2 inflammation durably imprints memory CD4 T cells
Sophie L. Gray-Gaillard, Sabrina Solis, H. Chen, et al.
Science Immunology (2024) Vol. 9, Iss. 96
Closed Access | Times Cited: 5
mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-γ and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity
Philip Samaan, Chapin S. Korosec, Patrick Budylowski, et al.
Journal of Virology (2025)
Open Access
Longitudinal analysis of immune responses to SARS-CoV-2 recombinant vaccine S-268019-b in phase 1/2 prime-boost study
Masaya Fujitani, Xiuyuan Lu, Ryo Shinnakasu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
In-silico evaluation of adenoviral COVID-19 vaccination protocols: Assessment of immunological memory up to 6 months after the third dose
Paola Stolfi, Filippo Castiglione, Enrico Mastrostefano, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients
Hendrik Luxenburger, David B. Reeg, Julia Lang‐Meli, et al.
Journal of Hepatology (2023) Vol. 78, Iss. 5, pp. 1017-1027
Open Access | Times Cited: 13
Current understanding of T cell immunity against SARS-CoV-2
Xiuyuan Lu, Sho Yamasaki
Inflammation and Regeneration (2022) Vol. 42, Iss. 1
Open Access | Times Cited: 20
SARS-CoV-2 epitope-specific T cells: Immunity response feature, TCR repertoire characteristics and cross-reactivity
Gang Yang, Junxiang Wang, Ping Sun, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
A novel vaccine based on SARS-CoV-2 CD4+ and CD8+ T cell conserved epitopes from variants Alpha to Omicron
Iam Palatnik-de-Sousa, Zachary S. Wallace, Stephany Christiny Cavalcante, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 16
An updated review of epidemiological characteristics, immune escape, and therapeutic advances of SARS-CoV-2 Omicron XBB.1.5 and other mutants
Zongming Liu, Jiaxuan Li, Shanshan Pei, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 9
Evaluation of an RBD-nucleocapsid fusion protein as a booster candidate for COVID-19 vaccine
Bruno Vinicius Santos Valiate, Julia Castro, Tomás Gazzinelli Marçal, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110177-110177
Open Access | Times Cited: 2
SARS-CoV-2 - The Role of Natural Immunity: A Narrative Review
Sara Diani, Erika Leonardi, Attilio Cavezzi, et al.
(2022)
Open Access | Times Cited: 13
Role of different types of RNA molecules in the severity prediction of SARS-CoV-2 patients
Pratheeba Jeyananthan
Pathology - Research and Practice (2023) Vol. 242, pp. 154311-154311
Open Access | Times Cited: 7
A novel multi-antigenic parapoxvirus-based vaccine demonstrates efficacy in protecting hamsters and non-human primates against SARS-CoV-2 challenge
Alena Reguzova, Melanie Sigle, Felix Pagallies, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 6
Safety and efficacy of dendritic cell vaccine for COVID-19 prevention after 1-Year follow-up: phase I and II clinical trial final result
Jonny Jonny, Terawan Agus Putranto, Martina Lily Yana, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Breadth and Durability of SARS-CoV-2-Specific T Cell Responses following Long-Term Recovery from COVID-19
Thi Thu Thao Dang, Alitzel Anzurez, Kaori Nakayama‐Hosoya, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 5
Analysis of Cell Immunity for Children Infected with SARS-CoV-2 and Those Vaccinated against SARS-CoV-2 Using T-SPOT®.COVID
Tomohiro Oishi, Yuto Yasui, Atsushi Kato, et al.
Microorganisms (2024) Vol. 12, Iss. 5, pp. 975-975
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top